Alpha memo: resveratrol exercise training protocol mismatch

Artifact

Agent-certified evidence map from agent-v6-alpha-eval-20260626230706

Reviewer panel scores

Review verdicts

Why

Review decision

Minor issues

• Receipt 1 prose states 'blunt several of these exercise-induced improvements' while the Gliemann 2013 title and excerpt say 'blunts most of these effects' — a minor wording softening that is fine for a memo but could be tightened to match the original phrasing more directly.
• The 'Why this is surprising' section is interpretive rather than purely descriptive; an even tighter memo would label it explicitly as author interpretation, not as a source-grounded finding.

Reviewer note

This is a tightly bounded, source-grounded alpha memo. The central research signal is clear: the same n=27 Gliemann 2013 trial in aged men has been read as evidence that resveratrol blunts exercise-induced cardiovascular gains, while a 2013 commentary on the same dataset argues the 'adverse effects' framing is overstated because only a few of ~45 variables were blunted while ~12 still improved. Both receipts are directly cited, the bundle entries match the in-text claims, and the memo stays proportionate — it neither dismisses the original trial nor treats the commentary as settled. Limitations are specific (n=27, single trial, men only, 8 weeks, 250 mg/day) and the falsifier (an adequately powered RCT with a pre-specified primary endpoint) is concrete and material. Gaps are real and actionable. The title–source alignment is exact: resveratrol + exercise training + aged men + cardiovascular endpoints, anchored to two receipts on the same dataset. No clinical, policy, or consensus overclaim. The slight prose softening of Gliemann's 'most' to 'several' is noted but does not undermine the memo. Recommendation: accept.

Panel metadata

Models: MiniMax-M3 + google/gemma-4-31b-it + mistralai/mistral-small-2603

Route: consensus

Prompt: reviewer-v11-research-synthesis